The Future of Health: Why Proactive Care Starts With Your Data Ft. Nate Graville Of Geviti

What It Covers

Nate Graville explains how Gevity uses comprehensive blood testing with over 100 biomarkers, AI analysis, and personalized supplementation protocols to shift healthcare from reactive treatment to proactive disease prevention and longevity optimization.

Key Questions Answered

• •Blood testing frequency: Comprehensive panels twice yearly provide sufficient data for health optimization without excessive needle exposure. Testing over 100 biomarkers reveals hidden issues like nutritional deficiencies, inflammation markers, and cancer indicators that standard primary care panels miss entirely.
• •Supplement personalization: Flying blind with supplementation based on social media or word-of-mouth recommendations wastes money and risks toxicity. Gevity creates custom AM and PM supplement packs using pharmaceutical-grade ingredients from Simogen, dosed specifically based on individual blood work deficiencies and excesses.
• •Healthcare spending paradox: US healthcare spending increased from 7% of GDP in 1970 to 20% today while population health declined dramatically. This inverse relationship proves the reactive sick-care model fails compared to preventative approaches that address root causes before disease manifests.
• •Mortality prediction capability: Two years of continuous blood work data combined with wearable device metrics enables AI models to predict mortality risk five to ten years out with 95-98% accuracy. This allows proactive protocol adjustments to minimize death risk from natural causes.
• •Methylation testing importance: Many people on SSRIs or Adderall suffer psychiatric side effects because they cannot properly process standard B vitamins. Methylation testing identifies this issue, allowing methylated B vitamin supplementation to potentially eliminate the need for psychiatric medications entirely.